Nakatoh S, Fujimori K, Ishii S, Tamaki J, Okimoto N, Ogawa S, Iki M (2025) Impact of dementia and hip fracture onset on the healthcare and long-term care burden: healthcare and long-term care insurance data analyses in Sendai City, Japan. Geriatr Gerontol Int 25:677–685
Sobolev B, Sheehan KJ, Kuramoto L, Guy P (2015) Excess mortality associated with second hip fracture. Osteoporos Int 26:1903–1910
Article CAS PubMed Google Scholar
Lee SH, Chen IJ, Li YH, Fan Chiang CY, Chang CH, Hsieh PH (2016) Incidence of second hip fractures and associated mortality in Taiwan: a nationwide population-based study of 95,484 patients during 2006–2010. Acta Orthop Traumatol Turc 50:437–442
Article PubMed PubMed Central Google Scholar
Trevisan C, Bedogni M, Pavan S, Shehu E, Piazzani F, Manzato E, Sergi G, March A (2020) The impact of second hip fracture on rehospitalization and mortality in older adults. Arch Gerontol Geriatr 90:104175
Barrionuevo P, Kapoor E, Asi N, Alahdab F, Mohammed K, Benkhadra K, Almasri J, Farah W, Sarigianni M, Muthusamy K, Al Nofal A, Haydour Q, Wang Z, Murad MH (2019) Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis. J Clin Endocrinol Metab 104:1623–1630
Wang PW, Li YZ, Zhuang HF, Yu HM, Cai SQ, Xu H, Chen ZH, Lin JK, Yao XD (2019) Anti-osteoporosis medications associated with decreased mortality after hip fracture. Orthop Surg 11:777–783
Article PubMed PubMed Central Google Scholar
Yu SF, Cheng JS, Chen YC, Chen JF, Hsu CY, Lai HM, Ko CH, Chiu WC, Su YJ, Cheng TT (2019) Adherence to anti-osteoporosis medication associated with lower mortality following hip fracture in older adults: a nationwide propensity score-matched cohort study. BMC Geriatr 19:290
Article PubMed PubMed Central Google Scholar
Tai TW, Li CC, Huang CF, Chan WP, Wu CH (2020) Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study. Bone 154:116216
Dobre R, Niculescu DA, Petca RC, Popescu RI, Petca A, Poiană C (2021) Adherence to anti-osteoporotic treatment and clinical implications after hip fracture: a systematic review. J Pers Med 11:341
Article PubMed PubMed Central Google Scholar
Yamanashi A, Yamazaki K, Kanamori M, Mochizuki K, Okamoto S, Koide Y, Kin K, Nagano A (2005) Assessment of risk factors for second hip fractures in Japanese elderly. Osteoporos Int 16:1239–1246
Banefelt J, Åkesson KE, Spångéus A, Ljunggren O, Karlsson L, Ström O, Ortsäter G, Libanati C, Toth E (2019) Risk of imminent fracture following a previous fracture in a Swedish database study. Osteoporos Int 30:601–609
Article CAS PubMed PubMed Central Google Scholar
Balasubramanian A, Zhang J, Chen L, Wenkert D, Daigle SG, Grauer A, Curtis JR (2019) Risk of subsequent fracture after prior fracture among older women. Osteoporos Int 30:79–92
Article CAS PubMed Google Scholar
Nakatoh S, Fujimori K, Ishii S, Tamaki J, Okimoto N, Ogawa S, Iki M (2021) Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip and vertebral fracture: analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Arch Osteoporos 16:130
Suzuki A, Sekiguchi-Ueda S, Kakita A (2015) Hip fracture--epidemiology, management and liaison service. Osteoporosis liaison service in Japan (in Japanese). Clin Calcium 25:559–563
Ministry of Health, Labour and Welfare (2025) Trends in the outbreak of new coronavirus infections in Japan (in Japanese). https://www.mhlw.go.jp/content/10906000/001094012.pdf. Accessed 3 Nov 2025
Kocijan R, Stockinger T, Haschka J, Reichardt B, Resch H, Zwerina J, Behanova M (2022) Dispensing anti-osteoporotic drugs changed during the COVID-19 pandemic. Bone 162:116477
Article CAS PubMed PubMed Central Google Scholar
Hu CL, Zheng MJ, He XX, Liu DC, Jin ZQ, Xu WH, Lin PY, Cheng JW, Wei QG (2023) COVID-19 and bone health. Eur Rev Med Pharmacol Sci 27:3191–3200
Outline of the revision of medical fees in FY4 of Reiwa (in Japanese). https://www.mhlw.go.jp/content/12400000/000912336.pdf. Accessed 3 Nov 2025
Ministry of Health, Labour, and Welfare (2025) User manual for individuals considering access to the NDB—November 2025 Version (in Japanese) https://www.mhlw.go.jp/content/12400000/001588818.pdf. Accessed 3 Nov 2025
Ministry of Health, Labour, and Welfare (2025) The popularization and state of electronic receipt claims (in Japanese). https://www.mhlw.go.jp/file/06-Seisakujouhou-12400000-Hokenkyoku/0000099002.pdf. Accessed 3 Nov 2025
The Japanese Orthopaedic Association (2022) Results of the national survey of hip fractures in 2022 (in Japanese). https://joints.joa.or.jp/member_site/committee/osteoporosis/pdf/femur22.pdf. Accessed 3 Nov 2025
Sheikh HQ, Hossain FS, Khan S, Usman M, Kapoor H, Aqil A (2019) Short-term risk factors for a second hip fracture in a UK population. Eur J Orthop Surg Traumatol 29:1055–1060
Article PubMed PubMed Central Google Scholar
Zidrou C, Vasiliadis AV, Rizou S, Beletsiotis A (2023) Second hip fracture in older adults: incidence and risk factors. Eur J Orthop Surg Traumatol 33:1599–1606
Ratnasamy PP, Rudisill KE, Oghenesume OP, Riedel MD, Grauer JN (2023) Risk of contralateral hip fracture following initial hip fracture among geriatric fragility fracture patients. J Am Acad Orthop Surg Glob Res Rev 7:e23.00001
PubMed PubMed Central Google Scholar
Chen M, Li Y, Yang Y, Zhuang W (2024) Analysis of the risk factors for contralateral refracture after hip fracture surgery in elderly individuals: a retrospective study. J Orthop Surg Res 19:681
Article PubMed PubMed Central Google Scholar
Bass E, French DD, Bradham DD, Rubenstein LZ (2007) Risk-adjusted mortality rates of elderly veterans with hip fractures. Ann Epidemiol 17:514–519
Keaveny TM, Adams AL, Orwoll ES, Khosla S, Siris ES, McClung MR, Bouxsein ML, Fatemi S, Lee DC, Kopperdahl DL (2024) Osteoporosis treatment prevents hip fracture similarly in both sexes: The FOCUS observational study. J Bone Miner Res 39:1424–1433
Article CAS PubMed PubMed Central Google Scholar
Li Q, Yang J, Tang Q, Feng Y, Pan M, Che M, Shi J, Zeng Y (2023) Age-dependent gender differences in the diagnosis and treatment of osteoporosis during hospitalization in patients with fragility fractures. BMC Geriatr 23:728
Article CAS PubMed PubMed Central Google Scholar
Hoit G, Whelan DB, Atrey A, Ravi B, Ryan G, Bogoch E, Davis AM, Khoshbin A (2022) Association of age, sex and race with prescription of anti-osteoporosis medications following low-energy hip fracture in a retrospective registry cohort. PLoS ONE 17:e0278368
Article CAS PubMed PubMed Central Google Scholar
Ekström W, Samuelsson B, Ponzer S, Cederholm T, Thorngren KG, Hedström M (2015) Sex effects on short-term complications after hip fracture: a prospective cohort study. Clin Interv Aging 10:1259–1266
Article PubMed PubMed Central Google Scholar
Jansen CP, Engdal M, Peter RS, Helbostad JL, Taraldsen K, Vereijken B, Pfeiffer K, Becker C, Klenk J (2024) Sex differences in mobility recovery after hip fracture: a time series analysis. Front Public Health 12:1434182
Article PubMed PubMed Central Google Scholar
Japan Osteoporosis Society (2015) Guidelines on the prevention and treatment of osteoporosis 2015. The committee for development of the guidelines on the prevention and treatment of osteoporosis (in Japanese). http://www.josteo.com/data/publications/guideline/2015_01.pdf. Accessed 3 Nov 2025
Hagino H, Wada T (2019) Osteoporosis liaison service in Japan. Osteoporos Sarcopenia 5:65–68
Article PubMed PubMed Central Google Scholar
Nakayama A, Major G, Holliday E, Attia J, Bogduk N (2016) Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate. Osteoporos Int 27:873–879
Article CAS PubMed Google Scholar
Andreasen C, Solberg LB, Basso T, Borgen TT, Dahl C et al (2018) Effect of a fracture liaison service on the rate of subsequent fracture among patients with a fragility fracture in the norwegian capture the fracture initiative (NoFRACT): a trial protocol. JAMA Netw Open 1:e185701
Comments (0)